‘Ghostly pyramid of light': Could ancient universal dust illuminate Kentucky skies?
KENTUCKY (FOX 56) — An eerie glow could be visible on clear nights in Kentucky now that the spring equinox has settled in.
According to EarthSky, zodiacal light can be seen extending up from the horizon as twilight ends. On nights with little to no ambient light from the moon, a ghostly glow shaped like a hazy pyramid of light can be seen for a time after the sun sets.
Originally, people believed that zodiacal light came from phenomena in the Earth's upper atmosphere, according to EarthSky.
One theory states that the cause of the glow can trace its origins back to the inception of the solar system approximately 4.5 billion light-years ago. Another theory claims that the celestial debris could originate from dust storms on Mars.
Either way, the ghostly lights that were described by Muhammad in the Koran and investigated by astronomer Giovanni Cassini continue to fascinate stargazers.
While typically easier to see in the southern hemisphere, stargazers in Kentucky and the rest of the northern hemisphere would need to travel away from city life to see Cassini's pyramids of light, EarthSky notes.
In the springtime, target areas where city lights don't obscure the rich array of natural light spread across the sky at night. The best time to try and view the zodiacal lights would be during a new moon or when the moon is at a slim crescent.
It's also best to try and see the lights during mostly to completely clear nights, where cloud cover is limited.
Given the upcoming string of severe storms and heavy rains forecasted for Kentucky over the next week, the next best available viewing date might be Monday, April 7, through Tuesday, April 8.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
an hour ago
- USA Today
June 2025 full moon: It's been years since you've seen one that looks like this
June 2025 full moon: It's been years since you've seen one that looks like this June's full moon, known as the strawberry moon, will rise on the evening of Tuesday, June 10. It will appear extraordinarily low in the sky. Show Caption Hide Caption Astronomy events to look out for the month of June Professor Chris Palma shares the top astronomy events to watch this June, from the Strawberry Moon to the summer solstice. June 2025's full moon is coming to a sky near you in the early morning hours of June 11. And while all June full moons ride low in the sky, spring's final full moon this year will be the lowest full moon in almost 20 years. The strawberry moon will rise on the evening of Tuesday, June 10, and will shine into Wednesday morning, a "sight that can be seen around the world," said Brian Lada, an AccuWeather meteorologist. June's full moon is called the strawberry moon because it signaled to some Native American tribes that it was the time of year to gather ripening wild strawberries, according to the Old Farmer's Almanac. Notably, this year's strawberry moon could actually have a reddish glow, due to how low it will sit in the sky and the haze from wildfires. When is the full strawberry moon? June's full moon will reach peak illumination on June 11, 2025, at 3:44 a.m. ET, the Almanac said. But it will look plenty full as it rises the evening before, June 10. Why could it be colorful? The strawberry moon is the most colorful of the year because it takes a low, shallow path across the sky, said Bob Bonadurer, director of the Milwaukee Public Museum's planetarium. The June full moon's arc across the sky means moonlight must travel through more of the Earth's atmosphere, which can give it a colorful tint. "So there's a chance it will actually look a little bit reddish or pink, and, and so that may also be part of the origin of the name," Chris Palma, professor of astronomy and astrophysics at Penn State University, told AccuWeather. Smoke in the atmosphere from Canadian wildfires could also act to create a colorful moon. Why so low in the sky this year? Blame the 'major lunar standstill' According to EarthSky, the moon will the lowest in the sky that it's been since 2006. "That's because we're in the midst of a major lunar standstill," which has to do with the moon's orbit around the Earth. "It's all about the inclination of the moon's orbit, which undergoes an 18.6-year cycle," noted EarthSky's John Jardine Goss. "The cycle happens because the moon's orbit is being slowly dragged around – mostly due to the pull of the sun – every 18.6 years." This year's major lunar standstill culminated in January 2025. And we're still close enough to it that the standstill is affecting the path of this June full moon, EarthSky said.
Yahoo
3 hours ago
- Yahoo
Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025
Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate (PPi) efflux via on-target engagement of the ABCC6 membrane transporter and reduced vascular calcification in animal models of CKD BOSTON, June 06, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., ('Rectify') a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today showcased new data from its cardiorenal program with its ABCC6-targeting PFM, RTY-822. The results were presented in an oral presentation during the European Renal Association (ERA) 2025 Congress, taking place in Vienna, Austria, June 4 – 7, 2025. 'These translational results demonstrate that Rectify's PFM reduces vascular calcification and kidney injury and improves kidney function through enhancement of ABCC6 function,' said Rajesh Devraj, Ph.D., President and Chief Executive Officer of Rectify. 'We believe the strength of these data underscores the potential of our approach to offer a novel and differentiated therapeutic strategy to treat renal dysfunction and injury, as well as address vascular calcification driving cardiovascular disease. We are committed to continuing to advance meaningful therapies for patients with CKD and serious cardiovascular conditions.' Robert Hughes, Ph.D., Chief Scientific Officer of Rectify, added, 'Enhancing the function of ABCC6 holds the potential to address key drivers of vascular calcification and tubular dysfunction seen in CKD. With demonstrated on-target engagement, RTY-822 shows significant promise to reduce CKD-associated calcium deposits in arterial walls, a well-established contributor to cardiovascular morbidity and mortality seen in patients with CKD, and remarkably, also improves glomerular function and tubular injury. The translational readiness of this program makes it a compelling de-risked asset with the potential to address CKD and multiple cardiovascular indications.' Title: A Positive Functional Modulator of ABCC6 Decreases Vascular Calcification and Improves Kidney Function in a Rat Adenine Diet Model of Chronic Kidney DiseaseAbstract Number: 1723 Presenter: John Miller, Ph.D. Session: Chronic Kidney Disease, Focused Oral Room 4Date and Time: Friday, June 6, 2025, 8:51 a.m. – 8:57 a.m. CEST In CKD, reduced ABCC6 activity or expression may lead to lower PPi levels, contributing to pathological calcification in blood vessels and kidneys. Restoring ABCC6 function or enhancing its expression offers a new and compelling therapeutic strategy to prevent the progression of CKD towards end-stage renal disease in addition to reducing large vessel calcification, a major driver of cardiovascular complications in CKD. Key findings RTY-822, an orally administered PFM targeting ABCC6 increased both ABCC6 protein expression and plasma PPi levels in primary human hepatocytes, supporting its proposed mechanism of action In a rat model of CKD and vascular calcification induced by an adenine-enriched diet with calcitriol supplementation: RTY-822 treatment led to statistically significant reductions in vascular calcification in the aorta and the femoral arteries After a six-week treatment course, RTY-822 improved glomerular and tubular kidney functions, with statistically significant reductions in serum creatinine, urea, and cystatin C, and an improved estimated glomerular filtration rate (eGFR) Calcium accumulation in the kidney was also significantly reduced Kidney injury biomarkers were reduced, including a significant decrease in plasma KIM-1 and urinary Lipocalin-2 (NGAL) levels In rats fed an adenine-rich diet without calcitriol supplementation, treatment with RTY-822 resulted in: Improved glomerular and tubular kidney functions Reduced serum creatinine and cystatin C levels Increased eGFR Reduced urinary NGAL levels, a biomarker of acute kidney injury The presentation is available on the Rectify website at About Rectify Pharmaceuticals, Inc. ('Rectify') Rectify is advancing Positive Functional Modulators (PFMs), a novel class of oral, small molecules that restore and enhance membrane protein function to address the underlying cause of serious diseases. Rectify's PFMs have potential to modulate the activity of wild-type and mutated membrane-bound proteins, a historically difficult challenge with a small molecule approach. The Company's breakthrough product platform enables efficient and rapid discovery of first- and best-in-class small molecule therapies with the potential to address membrane protein dysfunction for treatment of rare and common diseases, including liver, cardio-renal-metabolic, and neurodegenerative diseases. Rectify was founded and seeded by Atlas Venture who co-led the $100M Series A round with Omega Funds and were joined by Forbion and Longwood Fund. For more information, please visit or follow us on X and LinkedIn. ContactMediaJonathan PappasLifeSci Communicationsjpappas@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
The Arietid Meteor Shower Will Peak Soon—Here's How to See Its Dazzling Shooting Stars
If you love stargazing, you're likely used to staying up late to catch celestial events. But to view the meteor shower currently lighting up the sky, you'll need to wake up extra early. According to EarthSky, the Arietids are the most active daytime meteor shower. From now until June 17, you might be able to spot the Arietid meteor shower during the early morning hours right before dawn, with its peak predicted around the morning of Saturday, June 7. According to NASA, meteor showers occur when Earth passes through the trails of debris left behind by comets or asteroids. When Earth's orbit intersects these trails, the debris (known as meteoroids) enters the Earth's atmosphere at high speeds, creating bright streaks of light we see as meteors or shooting stars. To spot this month's meteor shower, face east and watch for meteors moving away from the radiant, which is the point in the sky from which the meteors appear to originate. The Arietids radiant is located in the constellation Aries, which you'll find in the eastern sky before sunrise. Streaks of light will move out in all directions from this point, with some moving upward into the predawn sky. Check when the sun rises in your area and plan to start viewing the spectacle an hour before then. For the best view, NASA recommends traveling away from city lights. While it's tricky to see daytime meteor showers once the sun comes up, the Arietid meteor shower has a strong zenithal hourly rate, which means there's usually a lot of activity. Per EarthSky, this shower has an impressive rate of 60 to 200 meteors per hour. That said, it will be daytime when the shower's radiant is overhead, so its maximum beauty is challenging to see. But you may have the chance to spot a few shooting stars if you look up before the sun rises. Read the original article on Martha Stewart
